JD Health and Jointown have inked a strategic cooperation pact, whereby both entities will leverage their core competencies across diverse domains and embark on an in-depth collaboration spanning multiple facets, such as supply chain, fulfillment, consumer engagement scenarios, and digital procurement. Their shared objective is to realize a collaboration scale surpassing 10 billion yuan within the next three years. Prior to this, the two parties had already laid a robust groundwork for cooperation, witnessing a 32% year-on-year surge in collaboration scale by the first half of 2026. As per the outlined plan, the duo will co-construct an exclusive supply chain, expedite the strategic deployment and management of pivotal products, and jointly establish an O2O instant retail sector. Concurrently, they will also engage in comprehensive, all-scenario cooperation within the non-pharmaceutical realm, crafting an integrated "products + health services" solution. Furthermore, the two sides will intensify their collaborative efforts in areas including digital procurement, warehousing and logistics, supply chain finance, AI-driven solutions, and digital transformation. Looking ahead, JD Health is poised to collaborate with additional partners to collectively propel the advancement and evolution of the pharmaceutical and healthcare sector.